Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proteins are susceptible to various non-enzymatic post-translational modifications occurring during aging and in certain pathological states. The
protein L-isoaspartyl methyltransferase
(
PIMT
) is an enzyme that recognizes and repairs the abnormal L-isoaspartyl residues in proteins. Recently, we reported that
PIMT
expression was stimulated by the anti-epileptic drug valproic acid and that this was mediated through the glycogen synthase kinase-3 (GSK-3)/beta-catenin pathway. In this study, to gain further insights into which of the signaling pathways activated by valproic acid regulate
PIMT
abundance, astrocytoma U-87 MG and
neuroblastoma
SH-SY5Y cells were treated with this drug to investigate the possible involvement of the extracellular-regulated kinase (ERK) pathway in
PIMT
induction. Valproic acid increased ERK1/2 phosphorylation on Thr202/Tyr204 and Thr185/Tyr187, respectively. Pharmacological inhibitors against the kinases Src, c-Raf, MEK1/2 and ERK1/2 abolished the ERK1/2 phosphorylation stimulated by valproic acid, thus preventing
PIMT
induction by the drug. Furthermore, MEK1/2 inhibition with U0126 blocked the higher phosphorylation of RSK-1 on Thr359/Ser363 and of GSK-3beta on Ser9 as well as the increased expression of RSK-1, beta-catenin and
PIMT
upon treatment with valproic acid. RSK-1 knockdown by interfering RNA abrogated the increased expression of RSK-1, beta-catenin and
PIMT
as well as the induced phosphorylation of RSK-1 and GSK-3beta due to valproic acid. Thus, our findings demonstrated that
PIMT
up-regulation by valproic acid required the activation of the ERK signaling pathway including RSK-1 the latter being responsible for inactivating GSK-3 and subsequently leading to beta-catenin stabilization.
...
PMID:Valproic acid enhances protein L-isoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway. 1937 92
The
protein L-isoaspartyl methyltransferase
(
PIMT
) repairs damaged aspartyl residues in proteins. It is commonly described as a cytosolic protein highly expressed in brain tissues. Here, we report that
PIMT
is an active monomeric as well as a multimeric protein in mitochondria isolated from
neuroblastoma
cells. Upon treatments with mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP),
PIMT
monomers level decreased by half while that of
PIMT
multimers was higher. Gel electrophoresis under reducing conditions of CCCP-induced
PIMT
multimers led to
PIMT
monomers accumulation, indicating that multimers resulted from disulfide-linked
PIMT
monomers. The antioxidant ascorbic acid significantly lowered CCCP-induced formation of
PIMT
multimers, suggesting that reactive oxygen species contributed to
PIMT
multimerization. In addition, the elevation of
PIMT
multimers catalytic activity upon treatments with CCCP was severely inhibited by the reducing agent dithiothreitol. This indicated that
PIMT
monomers have lower enzymatic activity following CCCP treatments and that activation of
PIMT
multimers is essentially dependent on the formation of disulfide-linked monomers of
PIMT
. Furthermore, the perturbation of mitochondrial function by CCCP promoted the accumulation of damaged aspartyl residues in proteins with high molecular weights. Thus, this study demonstrates the formation of active
PIMT
multimers associated with mitochondria that could play a key role in repairing damaged proteins accumulating during mitochondrial dysfunction.
...
PMID:Mitochondrial uncoupler carbonyl cyanide M-chlorophenylhydrazone induces the multimer assembly and activity of repair enzyme protein L-isoaspartyl methyltransferase. 2331 67